Javascript must be enabled to continue!
ADVERSE DRUG REACTION IN PEOPLE WITH EPILPSY
View through CrossRef
OBJECTIVES: There is a need for early identification and intervention of
Adverse Drug Reaction (ADR) to alleviate unacceptably growing burden,
morbidity and mortality associated in People With Epilepsy (PWE). This
study is aimed at identifying factors associated with ADR and medication
adherence among patients in PWE. METHODS: It is a cross-sectional
questionnaire-based study consisting of 940 consenting participants aged
16 years and above attending epilepsy clinics for period of 5years with
diagnosis confirmed by International League against Epilepsy (ILAE)
criteria and supported by Electroencephalography (EEG). 21-item
Liverpool Adverse Effect Profile (LEAP) and 8-item. Morinsky Medication
Adherence Scale (MMAS) were used to assess ADR and adherence
respectively. RESULTS: The highest reported ADR in PWE were nervousness
(34.3%), aggression (33.6%) and weight gain (32.3%). Specifically,
(20.1%) of the participant complained of memory problem, while the
lowest were hair loss (7.2%), trouble with mouth (8.9%) and problem
with skin (9.3%). Using the MMAS, 545(90.2%), 28(4.6%) and 31(5.1%)
of PWE in this study were classified as having high, medium, and low
adherence, respectively. Duration of AEDs use and duration of epilepsy
were the major determinant of ADR in PWE on regression model.
CONCLUSION: Duration of AEDs use and duration of epilepsy are the major
determinant of ADR in PWE. Effective strategies to identify and reduce
ADR should be incorporated to management of PWE by Health Care Providers
to improve their quality of life. Furthermore, physician should aim
towards reducing the duration of AED use and the epilepsy.
Title: ADVERSE DRUG REACTION IN PEOPLE WITH EPILPSY
Description:
OBJECTIVES: There is a need for early identification and intervention of
Adverse Drug Reaction (ADR) to alleviate unacceptably growing burden,
morbidity and mortality associated in People With Epilepsy (PWE).
This
study is aimed at identifying factors associated with ADR and medication
adherence among patients in PWE.
METHODS: It is a cross-sectional
questionnaire-based study consisting of 940 consenting participants aged
16 years and above attending epilepsy clinics for period of 5years with
diagnosis confirmed by International League against Epilepsy (ILAE)
criteria and supported by Electroencephalography (EEG).
21-item
Liverpool Adverse Effect Profile (LEAP) and 8-item.
Morinsky Medication
Adherence Scale (MMAS) were used to assess ADR and adherence
respectively.
RESULTS: The highest reported ADR in PWE were nervousness
(34.
3%), aggression (33.
6%) and weight gain (32.
3%).
Specifically,
(20.
1%) of the participant complained of memory problem, while the
lowest were hair loss (7.
2%), trouble with mouth (8.
9%) and problem
with skin (9.
3%).
Using the MMAS, 545(90.
2%), 28(4.
6%) and 31(5.
1%)
of PWE in this study were classified as having high, medium, and low
adherence, respectively.
Duration of AEDs use and duration of epilepsy
were the major determinant of ADR in PWE on regression model.
CONCLUSION: Duration of AEDs use and duration of epilepsy are the major
determinant of ADR in PWE.
Effective strategies to identify and reduce
ADR should be incorporated to management of PWE by Health Care Providers
to improve their quality of life.
Furthermore, physician should aim
towards reducing the duration of AED use and the epilepsy.
Related Results
Isolation, characterization and semi-synthesis of natural products dimeric amide alkaloids
Isolation, characterization and semi-synthesis of natural products dimeric amide alkaloids
Isolation, characterization of natural products dimeric amide alkaloids from roots of the Piper chaba Hunter. The synthesis of these products using intermolecular [4+2] cycloaddit...
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
BACKGROUND
As of July 2020, a Web of Science search of “machine learning (ML)” nested within the search of “pharmacokinetics or pharmacodynamics” yielded over 100...
Piece by piece: Collaborative mosaic-making for inclusive policy development
Piece by piece: Collaborative mosaic-making for inclusive policy development
This report sets out the findings from one of four projects commissioned by Wellcome Policy Lab to pilot creative approaches to policy development. In this project, Scientia Script...
Development, Testing, and Findings of a Pediatric-Focused Trigger Tool to Identify Medication-Related Harm in US Children's Hospitals
Development, Testing, and Findings of a Pediatric-Focused Trigger Tool to Identify Medication-Related Harm in US Children's Hospitals
OBJECTIVES. The purposes of this study were to develop a pediatric-focused tool for adverse drug event detection and describe the incidence and characteristics of adverse drug even...
Awareness of Adverse Drug Reactions and its Reporting among Third-year Undergraduate Medical Students
Awareness of Adverse Drug Reactions and its Reporting among Third-year Undergraduate Medical Students
Background: Drug is a double-edged sword. Though important, Adverse Drug Reactions under-reporting is real and is mainly due to lack of awareness. No published research has ever ev...
A Study of Adverse Drug Effects in Patients with Obsessive Compulsive Disorder
A Study of Adverse Drug Effects in Patients with Obsessive Compulsive Disorder
Aims: To identify and record adverse effects/adverse drug reactions in patients receiving pharmacotherapy for obsessive compulsive disorder (OCD) visiting Psychiatry Out patient de...
Studi Literatur Kasus Adverse Drug Reactions Dari Pengaruh Bahan Eksipien Obat
Studi Literatur Kasus Adverse Drug Reactions Dari Pengaruh Bahan Eksipien Obat
Abstract. Adverse Drug Reactions (ADRs) are generally triggered by active substances contained in the drugs used, but it is possible that these ADR events are caused and triggered ...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...

